Aug 12, 2026 07:30AM
May 13, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 4, 2024 08:35AM
Apr 4, 2024 08:30AM
Feb 29, 2024 07:30AM Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Jan 8, 2024 07:36AM
Jan 8, 2024 07:30AM
Nov 7, 2023 07:30AM
Nov 7, 2023 07:15AM
Nov 7, 2023 07:15AM
Oct 11, 2023 08:05AM
Sep 11, 2023 04:15PM Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended
Aug 3, 2023 07:30AM
May 4, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM
Feb 28, 2022 09:30AM
Nov 4, 2021 07:30AM Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 4, 2021 07:30AM
Aug 5, 2021 07:30AM
Aug 5, 2021 07:30AM
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM
Dec 17, 2020 09:22AM Pre-Open Stock Movers 12/17: (XSPA) (MGNX) (RAD) (ROKU) Higher; (QTT) (PHAT) (ABM) Lower (more...)
May 11, 2020 09:28AM
Feb 10, 2020 09:21AM
Aug 5, 2019 07:30AM
Aug 5, 2019 07:30AM
Jul 2, 2019 04:03PM
Jul 2, 2019 04:01PM
Jul 2, 2019 04:01PM Arbutus Sells Part of its ONPATTRO™ (patisiran) Royalty Interest to OMERS
May 6, 2019 04:01PM
May 6, 2019 04:01PM
Mar 7, 2019 04:01PM
Mar 7, 2019 04:01PM
Nov 7, 2018 04:01PM
Nov 7, 2018 04:01PM
Aug 13, 2018 08:33AM Arbutus Biopharma (ABUS) Licensee Alnylam Pharmaceuticals (ALNY) Reports FDA Approval of ONPATTRO (patisiran) for Treatment of ATTR Amyloidosis
Aug 13, 2018 08:30AM
Aug 13, 2018 08:30AM
Aug 2, 2018 04:00PM
Aug 2, 2018 04:00PM
Jul 10, 2018 07:00AM
Jul 10, 2018 07:00AM
Mar 15, 2018 09:27AM Pre-Open Movers 03/15: (SMRT) (RUBI) (CWAY) Higher; (SLDB) (JILL) (SPEX) Lower (more...)
Mar 14, 2018 04:00PM

328,448 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All